According to Zhitong Finance App, Rongchang Biotech (09995.HK) issued an announcement. On October 14, 2026, the company further concluded (1) SPD Bank Wealth Management Product No. 12 agreement with SPD Bank Yantai Branch. According to this, the Company agreed to use RMB 70 million of idle raised capital to purchase wealth management products from SPD Bank Yantai Branch; and (2) SPD Bank Wealth Management Products No. 13. Based on this, the Company agreed to use RMB 300 million of idle capital to purchase wealth management products from SPD Bank Yantai Branch.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.